New Key Statistics Module, Z-Score and F-Score
SZSE:002898 Key Ratios
Market Cap ¥ M | 1,703.68 |
Enterprise Value ¥ M | 1,740.56 |
P/E(ttm) | 210.43 |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 3.17 |
Price/Sales | 5.67 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 300.00 |
EPS (TTM) ¥ | 0.05 |
Beneish M-Score | -2.5 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 62.72 |
EV-to-EBITDA | 62.72 |
PEG | -- |
Shares Outstanding M | 176.00 |
Net Margin (%) | 2.65 |
Operating Margin % | 5.23 |
Pre-tax Margin (%) | 6.81 |
Quick Ratio | 0.76 |
Current Ratio | 1.15 |
ROA % (ttm) | 0.97 |
ROE % (ttm) | 1.49 |
ROIC % (ttm) | 0.87 |
Dividend Yield % | -- |
Altman Z-Score | 4.71 |
SZSE:002898 Number of Guru Trades
SZSE:002898 Volume of Guru Trades
Gurus Latest Trades with SZSE:002898
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002898 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Sailong Pharmaceutical Group Co Ltd Insider Transactions
No Available Data